| Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR* D report AJ Rush, MH Trivedi, SR Wisniewski, AA Nierenberg, JW Stewart, ... American Journal of Psychiatry 163 (11), 1905-1917, 2006 | 6010 | 2006 |
| Evaluation of outcomes with citalopram for depression using measurement-based care in STAR* D: implications for clinical practice MH Trivedi, AJ Rush, SR Wisniewski, AA Nierenberg, D Warden, L Ritz, ... American journal of Psychiatry 163 (1), 28-40, 2006 | 4525 | 2006 |
| Major depressive disorder C Otte, SM Gold, BW Penninx, CM Pariante, A Etkin, M Fava, DC Mohr, ... Nature reviews Disease primers 2 (1), 1-20, 2016 | 2134 | 2016 |
| Diagnosis and definition of treatment-resistant depression M Fava Biological psychiatry 53 (8), 649-659, 2003 | 1728 | 2003 |
| Reduced caudate and nucleus accumbens response to rewards in unmedicated individuals with major depressive disorder DA Pizzagalli, AJ Holmes, DG Dillon, EL Goetz, JL Birk, R Bogdan, ... American Journal of Psychiatry 166 (6), 702-710, 2009 | 1351 | 2009 |
| Bupropion-SR, sertraline, or venlafaxine-XR after failure of SSRIs for depression AJ Rush, MH Trivedi, SR Wisniewski, JW Stewart, AA Nierenberg, ... New England Journal of Medicine 354 (12), 1231-1242, 2006 | 1337 | 2006 |
| Medication augmentation after the failure of SSRIs for depression MH Trivedi, M Fava, SR Wisniewski, ME Thase, F Quitkin, D Warden, ... New England Journal of Medicine 354 (12), 1243-1252, 2006 | 1325 | 2006 |
| A mega-analysis of genome-wide association studies for major depressive disorder Major Depressive Disorder Working Group of the Psychiatric GWAS Consortium Molecular psychiatry 18 (4), 2013 | 1273 | 2013 |
| Sequenced treatment alternatives to relieve depression (STAR* D): rationale and design AJ Rush, M Fava, SR Wisniewski, PW Lavori, MH Trivedi, HA Sackeim, ... Controlled clinical trials 25 (1), 119-142, 2004 | 1172 | 2004 |
| Definition and epidemiology of treatment-resistant depression M Fava, KG Davidson Psychiatric Clinics of North America 19 (2), 179-200, 1996 | 1137 | 1996 |
| Harmonization of cortical thickness measurements across scanners and sites JP Fortin, N Cullen, YI Sheline, WD Taylor, I Aselcioglu, PA Cook, ... Neuroimage 167, 104-120, 2018 | 1020 | 2018 |
| Difference in treatment outcome in outpatients with anxious versus nonanxious depression: a STAR* D report M Fava, AJ Rush, JE Alpert, GK Balasubramani, SR Wisniewski, ... American Journal of Psychiatry 165 (3), 342-351, 2008 | 1010 | 2008 |
| Depression and public health: an overview P Cassano, M Fava Journal of psychosomatic research 53 (4), 849-857, 2002 | 993 | 2002 |
| Major depressive disorder M Fava, KS Kendler Neuron 28 (2), 335-341, 2000 | 980 | 2000 |
| Reduced hedonic capacity in major depressive disorder: evidence from a probabilistic reward task DA Pizzagalli, D Iosifescu, LA Hallett, KG Ratner, M Fava Journal of psychiatric research 43 (1), 76-87, 2008 | 922 | 2008 |
| Remissions in maternal depression and child psychopathology: a STAR* D-child report MM Weissman, DJ Pilowsky, PJ Wickramaratne, A Talati, SR Wisniewski, ... Jama 295 (12), 1389-1398, 2006 | 901 | 2006 |
| The STAR* D Project results: a comprehensive review of findings D Warden, AJ Rush, MH Trivedi, M Fava, SR Wisniewski Current psychiatry reports 9 (6), 449-459, 2007 | 873 | 2007 |
| Report by the ACNP Task Force on response and remission in major depressive disorder AJ Rush, HC Kraemer, HA Sackeim, M Fava, MH Trivedi, E Frank, ... Neuropsychopharmacology 31 (9), 1841-1853, 2006 | 832 | 2006 |
| STAR* D: what have we learned? AJ Rush American Journal of Psychiatry 164 (2), 201-204, 2007 | 793* | 2007 |
| What did STAR* D teach us? Results from a large-scale, practical, clinical trial for patients with depression BN Gaynes, D Warden, MH Trivedi, SR Wisniewski, M Fava, AJ Rush Psychiatric services 60 (11), 1439-1445, 2009 | 776 | 2009 |
David Alan SchoenfeldProfessor of MedicineVerified email at partners.org
